ReviewFrontiers in immunology2026

The emerging role of CRISPR-Cas systems in helicobacter pylori and the gut microbiota as regulators of gastrointestinal cancer risk.

Muqadas Bhatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.